Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies

Spencer, 2008, Diabetes and modifiable risk factors for cardiovascular disease: the prospective Million Women Study, Eur J Epidemiol, 23, 793, 10.1007/s10654-008-9298-3

Schramm, 2008, Diabetes patients requiring glucose-lowering therapy and nondiabetics with a prior myocardial infarction carry the same cardiovascular risk: a population study of 3.3 million people, Circulation, 117, 1945, 10.1161/CIRCULATIONAHA.107.720847

Huxley, 2006, Excess risk of fatal coronary heart disease associated with diabetes in men and women: meta-analysis of 37 prospective cohort studies, BMJ, 332, 73, 10.1136/bmj.38678.389583.7C

Kanaya, 2002, Explaining the sex difference in coronary heart disease mortality among patients with type 2 diabetes mellitus: a meta-analysis, Arch Intern Med, 162, 1737, 10.1001/archinte.162.15.1737

Woodward, 2003, The effects of diabetes on the risks of major cardiovascular diseases and death in the Asia-Pacific region, Diabetes Care, 26, 360, 10.2337/diacare.26.2.360

Janghorbani, 2007, Prospective study of type 1 and type 2 diabetes and risk of stroke subtypes: the Nurses' Health Study, Diabetes Care, 30, 1730, 10.2337/dc06-2363

Beckman, 2002, Diabetes and atherosclerosis: epidemiology, pathophysiology, and management, JAMA, 287, 2570, 10.1001/jama.287.19.2570

Coutinho, 1999, The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years, Diabetes Care, 22, 233, 10.2337/diacare.22.2.233

Lawes, 2004, Blood glucose and risk of cardiovascular disease in the Asia Pacific region, Diabetes Care, 27, 2836, 10.2337/diacare.27.12.2836

Helfand, 2009, Emerging risk factors for coronary heart disease: a summary of systematic reviews conducted for the U.S. Preventive Services Task Force, Ann Intern Med, 151, 496, 10.7326/0003-4819-151-7-200910060-00010

2007, Analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases, Eur J Epidemiol, 22, 839, 10.1007/s10654-007-9165-7

2009, Major lipids, apolipoproteins, and risk of vascular disease, JAMA, 302, 1993, 10.1001/jama.2009.1619

2010, Statistical methods for time-to-event analysis of individual participant data from multiple epidemiological studies, Int J Epidemiol

Easton, 1991, Floating absolute risk: an alternative to relative risk in survival and case-control analysis avoiding an arbitrary reference group, Stat Med, 10, 1025, 10.1002/sim.4780100703

Higgins, 2002, Quantifying heterogeneity in a meta-analysis, Stat Med, 21, 1539, 10.1002/sim.1186

2009, Measures to assess the prognostic ability of the stratified Cox proportional hazards model, Stat Med, 28, 389, 10.1002/sim.3378

Graubard, 2007, Estimation of attributable number of deaths and standard errors from simple and complex sampled cohorts, Stat Med, 26, 2639, 10.1002/sim.2734

2007, Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary, Eur Heart J, 28, 88

2007

Lopez, 2006

Creager, 2003, Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: Part I, Circulation, 108, 1527, 10.1161/01.CIR.0000091257.27563.32

Natali, 2000, Coronary atherosclerosis in Type II diabetes: angiographic findings and clinical outcome, Diabetologia, 43, 632, 10.1007/s001250051352

Waltenberger, 2001, Impaired collateral vessel development in diabetes: potential cellular mechanisms and therapeutic implications, Cardiovasc Res, 49, 554, 10.1016/S0008-6363(00)00228-5

2010, Diagnosis and classification of diabetes mellitus, Diabetes Care, 33, 62

Avendano, 2006, Blood glucose levels: facing a global crisis, Lancet, 368, 1631, 10.1016/S0140-6736(06)69675-X

Danaei, 2006, Global and regional mortality from ischaemic heart disease and stroke attributable to higher-than-optimum blood glucose concentration: comparative risk assessment, Lancet, 368, 1651, 10.1016/S0140-6736(06)69700-6

Kelly, 2008, Global burden of obesity in 2005 and projections to 2030, Intl J Obes, 32, 1431, 10.1038/ijo.2008.102

Gao, 2004, Post-challenge hyperglycaemia rather than fasting hyperglycaemia is an independent risk factor of cardiovascular disease events, Clin Lab, 50, 609

Sarwar, 2010, Markers of dysglycaemia and risk of coronary heart disease in people without diabetes: Reykjavik prospective study and systematic review, PloS Med, 7, e1000278, 10.1371/journal.pmed.1000278

Sarwar, 2007, Circulating concentrations of insulin markers and coronary heart disease: a quantitative review of 19 Western prospective studies, Eur Heart J, 249, 1